1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Unilever PLC
  6. News
  7. Summary
    ULVR   GB00B10RZP78

UNILEVER PLC

(ULVR)
  Report
Delayed London Stock Exchange  -  05/24 11:35:07 am EDT
3541.00 GBX   +0.06%
02:35pGlobal energy and funding shocks test climate commitments
RE
05/23Indian Benchmarks End Marginally Lower; JSW Steel Slumps 13%
MT
05/20Inflation crimps Indian firms as rural millions cut spending
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Unilever's soap opera: M&A, job cuts and grumpy investors

01/25/2022 | 06:31am EDT
FILE PHOTO: Illustration of Unilever logo

(Reuters) - Unilever unveiled plans on Tuesday to cut about 1,500 management jobs in an overhaul aimed at easing shareholders' concerns after a failed acquisition and news an activist investor had built a stake in the consumer goods giant.

The maker of Dove soap and Magnum ice cream has had a bumpy few years, with shares falling about a quarter from highs seen in late 2019, and CEO Alan Jope's plans facing scrutiny.

Here are key developments around Unilever in the past two months.

NOV. 18, 2021:

Unilever agreed to sell its global tea business to CVC Capital Partners for 4.5 billion euros ($5.1 billion), concluding a process of reviewing and spinning off the division that took more than two years.

JAN. 15, 2022:

Unilever confirmed it had approached GlaxoSmithKline about buying its consumer goods business following media reports.

Later in the day, GSK said it had rejected Unilever's 50-billion-pound ($68 billion) offer, saying it "fundamentally undervalued" the consumer healthcare business.

GSK said it had received the third approach from Unilever on Dec. 20 and that it comprised 41.7 billion pounds in cash and 8.3 billion in Unilever shares.

JAN. 17

Unilever signalled it would pursue a deal for GSK's consumer business, calling it a "strong strategic fit," but shares slid more than 8%. The company also said it would announce an initiative later in the month to strengthen its business.

JAN. 19

Late in the day, Unilever said it would not raise its offer for GSK's consumer healthcare business from 50 billion pounds. Sources had told Reuters GSK would not engage with Unilever unless the offer was sweetened.

JAN. 20

Unilever shares slipped on its short-lived pursuit of GSK's consumer health assets. Influential British fund manager Terry Smith criticised the failed bid as a "near death experience" and urged Unilever to focus on strengthening performance.

JAN. 23

A source told Reuters that activist investor Nelson Peltz's hedge fund, Trian Partners, had built a stake of an unspecified size in Unilever, ratcheting up pressure on the company, months after Peltz stepped down from rival P&G's board.

JAN. 24

Unilever shares rose 6% on reports of Peltz's stake.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Keith Weir and Mark Potter)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
GLAXOSMITHKLINE PLC 0.00% 1782 Delayed Quote.10.92%
THE WENDY'S COMPANY -2.43% 16.265 Delayed Quote.-30.15%
UNILEVER PLC 0.06% 3541 Delayed Quote.-10.30%
All news about UNILEVER PLC
02:35pGlobal energy and funding shocks test climate commitments
RE
05/23Indian Benchmarks End Marginally Lower; JSW Steel Slumps 13%
MT
05/20Inflation crimps Indian firms as rural millions cut spending
RE
05/19European ADRs Move Higher in Thursday Trading
MT
05/19London's FTSE 100 tumbles on global slowdown worries
RE
05/19European shares lower as retailers, food and beverage stocks lead falls
RE
05/19UNILEVER PLC : Ex-dividend day for interim dividend
FA
05/18UNITED WE STAND : Unilever Supports Systemic Change for LGBTQI+ Communities
BU
05/18Indian Indices Close in Red Midweek; Power Grid Corporation of India Drops 5%
MT
05/17WALL STREET STOCK EXCHANGE : Finding the tipping point
More news
Analyst Recommendations on UNILEVER PLC
More recommendations
Financials
Sales 2022 57 621 M 61 574 M 61 574 M
Net income 2022 5 639 M 6 026 M 6 026 M
Net Debt 2022 23 916 M 25 557 M 25 557 M
P/E ratio 2022 19,8x
Yield 2022 4,08%
Capitalization 107 B 114 B 114 B
EV / Sales 2022 2,27x
EV / Sales 2023 2,18x
Nbr of Employees 148 012
Free-Float 95,5%
Chart UNILEVER PLC
Duration : Period :
Unilever PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends UNILEVER PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 41,64 €
Average target price 47,14 €
Spread / Average Target 13,2%
EPS Revisions
Managers and Directors
Alan Jope Chief Executive Officer & Executive Director
Graeme David Pitkethly Chief Financial Officer & Executive Director
Nils Smedegaard Andersen Chairman
Richard Slater Chief Research & Development Officer
Nitin Paranjpe Chief Operating, Transformation & People Officer
Sector and Competitors
1st jan.Capi. (M$)
UNILEVER PLC-10.30%113 476
PROCTER & GAMBLE COMPANY-11.33%348 018
THE ESTÉE LAUDER COMPANIES INC.-36.09%84 548
HINDUSTAN UNILEVER LIMITED-2.15%72 159
COLGATE-PALMOLIVE COMPANY-10.34%64 119
RECKITT BENCKISER GROUP PLC-1.29%56 282